Children's Wisconsin's Appleton Clinic - opened March 2023 (photo: Dairy Cares of WI)
MADISON, WI (WTAQ-WRN) — Children ages 12 and older with sickle cell are eligible for a new treatment at Children’s Hospital of Wisconsin.
The newly FDA-approved treatment is called Casgevy, and works by adding a gene that makes fetal hemoglobin, which reduces the clinical effects of sickle cell disease.
Before this new gene therapy was approved, the typical treatment could include daily oral medication and a bone marrow transplant in addition to transfusions to remove excess iron from the blood.
The Children’s Wisconsin program currently provides care for about 400 children living with sickle cell disease.
Physicians estimate that the new treatment will include a two-month stay.
Comments